(Bloomberg) -- JPMorgan will no longer allow prime brokerage clients to buy U.S. cannabis-related stocks from Nov. 8, Reuters reports citing the firm’s letter to clients.
Company cites the U.S. anti-money laundering compliance framework as reason for new cannabis stocks policy in the letter
